ORPHA:98977
Juvenile glaucoma
Publications
6,149
93.7th percentile
Trials
0
Interventional, condition-specific
Researchers
992
Distinct authors in sample
Gene link
EFEMP1, MYOC
Definitive
Readiness
5/6
Stages with a signal
Clinical definition (Orphanet)
A rare primary early-onset glaucoma characterized by early onset, severe elevation of intra ocular pressure of rapid progression, leading to optic nerve excavation and, when untreated, substantial visual impairment.
How rare: 1-9 / 100 000 — about one to nine people per hundred thousand.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0020367
- UMLS:C2981140
Additional Mondo synonyms (7)
JOAG · childhood glaucoma (disease) · glaucoma (disease) of childhood · glaucoma of childhood · juvenile glaucoma · paediatric glaucoma (disease) · pediatric glaucoma (disease)
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
5/6 stages with a signal
No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.
- Gene identifiedPresent
Definitive — EFEMP1, MYOC
- LiteraturePresent
6,149 matched papers (3,944 in last 10 years) Source
- Phenotype characterisedPresent
21 HPO annotations (e.g. Visual impairment; Optic neuropathy; Abnormality iris morphology) Source
- Animal modelPresent
1 genotype model (Mus musculus) Source
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialPartial
None under the specific name; 1627 for broader category glaucoma
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (EFEMP1, MYOC).
GenCC classification: Definitive.
Phenotypes (Monarch / HPO)
21
Associated phenotypes · MONDO:0020367
- Visual impairment
- Optic neuropathy
- Abnormality iris morphology
- Abnormal optic nerve morphology
- Abnormal anterior chamber morphology
Showing 5 of 21 — open Monarch for the full list.
Animal models (Monarch / Alliance)
1
Model associations linked to this Mondo ID
- Pax6tm2Pgr/Pax6+ Tg(Pax6-cre,GFP)1Pgr/0 [background:] involves: 129S1/Sv * 129X1/SvJ * FVB·MGI:4821786·Mus musculus
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
6,149
6,149 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
6,149 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
3,944 in the last 10 years · medium confidence · 93.7th percentile (publications denominator)
Phrase hits: 1,090 · MeSH hits: 0
Who's working on it?
992
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Gupta V7 papers · 2025
Dr RP Center of Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Papers in Europe PMC - 02Hoffmann EM7 papers · 2026
Department of Ophthalmology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Papers in Europe PMC - 03Pfeiffer N7 papers · 2026
Department of Ophthalmology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Papers in Europe PMC - 04Schuster AK7 papers · 2026
Department of Ophthalmology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Papers in Europe PMC - 05Elhusseiny AM5 papers · 2025
Department of Ophthalmology, Harvey and Bernice Jones Eye Institute.
Papers in Europe PMC - 06Gupta S5 papers · 2025
Dr. Rajendra Prasad Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Papers in Europe PMC - 07Stingl JV5 papers · 2025
Department of Ophthalmology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Papers in Europe PMC - 08Wagner FM5 papers · 2025
Department of Ophthalmology, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
Papers in Europe PMC - 09Zhang Y5 papers · 2025
Department of Ophthalmology, West China Hospital of Sichuan University, Chengdu, China.
Papers in Europe PMC - 10Grehn F4 papers · 2024
Department of Ophthalmology, University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present). 1,627 trials are registered for glaucoma, the broader category — shown separately because they may or may not enrol this specific subtype.
Data as of 26 October 2026 · last trial check 26 October 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5498 of 7126). Here are the researchers publishing on it.
medium confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
1,627 interventional trials matched glaucoma, the broader category — listed below. Those studies are not counted in the condition-specific total.
Broader category: glaucoma
1,627
Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.
Worth raising with a clinician. How we count trials.
Recruiting under the broader category
- NCT07015034·RECRUITING·Developing and Testing a Model to Identify Preventive Vision Loss Among Older Patients in General Practice
Conditions: Vision Impairment and Blindness · Glaucoma · Age-Related Macular Degeneration · Cataract·Matched via name phrase
- NCT07075718·RECRUITING·Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Conditions: Glaucoma·Matched via name phrase
- NCT04957329·RECRUITING·Effect of Benzalkonium Chloride Preserved and Preservative-free Latanoprost Eye Drops on Conjunctival Goblet Cells
Conditions: Glaucoma · Ocular Hypertension·Matched via name phrase
- NCT05344274·RECRUITING·Retinal Blood Flow and Autoregulation
Conditions: Glaucoma·Matched via name phrase
- NCT07803536·NOT YET RECRUITING·Effect of Late Ripcord Removal From Glaucoma Drainage Device
Conditions: GLAUCOMA 1, OPEN ANGLE, D (Disorder) · Glaucoma·Matched via name phrase
- NCT06854198·RECRUITING·Glaucoma Screening to Enhance At-Risk Californians' Health
Conditions: Glaucoma·Matched via name phrase
- NCT07488234·NOT YET RECRUITING·Impact of a Glaucoma Awareness Program on Treatment Adherence
Conditions: Glaucoma·Matched via name phrase
- NCT06731582·ENROLLING BY INVITATION·Nicotinamide Supplementation in Glaucoma
Conditions: Glaucoma·Matched via name phrase
- NCT06680245·NOT YET RECRUITING·Effect of Mitomycin-C on the Outcomes of Patients Receiving Ahmed Glaucoma Valve Implantation Surgery
Conditions: Glaucoma·Matched via name phrase
- NCT06865235·RECRUITING·Efficacy and Safety of Gonioscopy Assisted Transluminal Trabeculotomy in Patients with Primary Open-angle Glaucoma and Cataract.
Conditions: Open Angle Glaucoma (OAG)·Matched via name phrase
- NCT07228221·RECRUITING·Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle Glaucoma
Conditions: Open Angle Glaucoma · Pigmentary Glaucoma · Pseudoexfoliation Glaucoma·Matched via name phrase
- NCT04401982·RECRUITING·Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects
Conditions: Ocular Hypertension · Suspect Glaucoma·Matched via name phrase
- NCT07847073·RECRUITING·Adaptive Optics OCT Evaluation of Rhopressa's Effects on the Retinal Ganglion Cells in Glaucoma Patients
Conditions: Open Angle Glaucoma (OAG) · Glaucoma·Matched via name phrase
- NCT05696561·RECRUITING·Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects With Open-Angle Glaucoma
Conditions: OAG - Open-Angle Glaucoma·Matched via name phrase
- NCT07777861·RECRUITING·A Phase II Trial of G01 Eye Drops for Glaucomatous Optic Neuropathy
Conditions: Primary Open-Angle Glaucoma · Optic Nerve Injury·Matched via name phrase
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 8 · after dedupe 8 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 8 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (8)
- isrctn·ISRCTN12427150·No longer recruiting·A study to see whether adalimumab or secukinumab is better for treating children and young people with juvenile idiopathic arthritis (JIA) associated uveitis or chronic anterior uveitis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN95363507·No longer recruiting·Tocilizumab in anti-TNF refractory patients with juvenile idiopathic arthritis (JIA) associated uveitis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10065623·No longer recruiting·The clinical effectiveness, safety and cost effectiveness of adalimumab in combination with methotrexate for the treatment of juvenile idiopathic arthritis associated uveitis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN05434212·No longer recruiting·Modernising the low vision clinic: the utility of a trained low vision support worker
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN71955482·No longer recruiting·The use of ß radiation as an adjunct to trabeculectomy in glaucoma
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10681798·No longer recruiting·A study to investigate the safety, tolerability, disposition in the body, effects of RO7308480 on the body, and its changes in midazolam disposition in the body following oral administration in healthy participants
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10584863·No longer recruiting·Psilocybin vs escitalopram for depression
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16827947·No longer recruiting·A Study of Concerta XL on reducing ADHD symptoms and behavioural problems in adult offenders with ADHD
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Juvenile glaucoma — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("Juvenile glaucoma" OR "childhood glaucoma (disease)" OR "glaucoma (disease) of childhood" OR "glaucoma (disease) of the childhood" OR "glaucoma of childhood" OR "glaucoma of the childhood" OR "paediatric glaucoma (disease)" OR "pediatric glaucoma (disease)") OR ("EFEMP1" OR "EFEMP1 syndrome" OR "EFEMP1-related" OR "MYOC" OR "MYOC syndrome" OR "MYOC-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Juvenile glaucoma" OR "childhood glaucoma (disease)" OR "glaucoma (disease) of childhood" OR "glaucoma (disease) of the childhood" OR "glaucoma of childhood" OR "glaucoma of the childhood" OR "paediatric glaucoma (disease)" OR "pediatric glaucoma (disease)"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Parent-category trials query:
"glaucoma"
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Synonyms dropped by stoplist: JOAG
Confidence reasoning
- Preferred label is multi-word and distinctive
- 1 synonym(s) dropped by stoplist (may under-count)
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T05:50:37.720Z
